All articles
Site OperationsOctober 9, 2026·3 min read

What a Screen Failure Actually Costs Your Site

A failed screen consumes coordinator hours, procedures, and room time that most contracts barely reimburse. Here's how to cost it out, separate avoidable failures from unavoidable ones, and fix the gap.

By Trialflow Team

Screen failures are the most expensive thing most sites refuse to measure. A failed screen consumes coordinator hours, lab draws, exam room time, physician review, and sometimes imaging — and in many budgets, reimburses a fraction of that. Sites commonly discover, when they finally cost it out, that screen failure absorbs a meaningful share of their study margin.

Here is how to look at it honestly and what to change.

Build the actual cost per screen failure

You cannot manage this without a number. Pull one study and add up what a single screening visit consumes:

  • Coordinator time: pre-screen call, consent, visit conduct, source documentation, EDC entry, query resolution. Multiply by loaded hourly rate, not salary.
  • Investigator time for eligibility review and physical exam.
  • Procedures not reimbursed on screen failure, or reimbursed below cost — central lab kits, ECGs, local labs, imaging.
  • Room and equipment occupancy that blocked a billable visit.
  • Participant stipend and travel reimbursement, which you usually pay regardless of outcome.

Then compare against the screen failure line in your budget. Many contracts cap screen failure payments, pay only for completed procedures, or require a sponsor-approved ratio. If your contract reimburses two screen failures per randomized participant and your actual ratio is four to one, the gap is real money leaving the building.

Distinguish avoidable from unavoidable

Not all screen failures are waste. A protocol gated on a central lab value you cannot predict will produce failures no process fixes. That is the cost of doing the study, and it belongs in your budget negotiation, not your process improvement plan.

The avoidable category looks different:

  1. Criteria you could have checked by phone — age, washout periods, prohibited medications, prior therapies, distance from site.
  2. Criteria you could have checked in the chart — recent labs, documented diagnoses, imaging within window.
  3. Criteria the participant could have self-reported accurately if you had asked a clearer question.

Track failure reason for every single screen failure, coded consistently. Within a few weeks the pattern is obvious: usually two or three reasons account for most of your avoidable failures. Those are your targets.

Push the gate earlier

The economics improve when the cheapest step does the most filtering. Practically:

  • Rewrite your pre-screen script around your top three avoidable failure reasons, with specific questions rather than general ones. "Have you taken a steroid tablet or injection in the last 90 days?" beats "Any other medications?"
  • Order a chart review step before scheduling, not after. A coordinator spending ten minutes in the EMR is far cheaper than a two-hour screening visit.
  • Where the protocol allows, split screening into two visits so the expensive procedures happen only after the cheap gates clear. Sponsors often agree to this if you ask during startup.
  • Feed failure patterns back to the sponsor. If an exclusion criterion is failing a third of your candidates and has little scientific weight, you are not the only site seeing it. Protocol amendments start with site data.

Negotiate with your own numbers

When you have per-reason failure data and a real cost per screen, screen failure budget conversations change character. You are not asking for more money; you are showing what the protocol's design costs to execute. Sites that bring that evidence to startup usually get better screen failure terms than sites that discover the problem in month six.

Measure it, categorize it, gate earlier, and price it into the contract. That sequence is the whole strategy.

Enrolling studies shouldn't be this hard

Trialflow gives research sites one platform for lead management, AI trial matching, and recruitment analytics.

Request a Demo